Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001641172-25-005139)

Filing Details

Accession Number:: 0001641172-25-005139
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-04-17 06:10:32
Reporting Period:: 2025-04-15

Filing Date:: 2025-04-17
Accepted Time:: 2025-04-17 06:10:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1574094	Renovorx Inc.	RNXT	Pharmaceutical Preparations (2834)	271448452

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1862617	Ramtin Agah	C/O Renovorx, Inc. 2570 W El Camino Real, Suite 320 Mountain View CA 94040	Chief Medical Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-04-15	15,000	$0.90	1,113,460	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Reflects open market purchases of the Issuer's securities.
The price reported is a weighted average price. These shares were purchased in multiple transactions. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.